Through the work of our Drugs and Therapeutics Committee, we help make sure medicines used across our Trust are safe, effective and based on the latest evidence and guidance.
The committee brings together patients, carers, doctors, nurses, pharmacists and other healthcare professionals. Together, they use clinical expertise and the experiences of patients and carers to make informed decisions about medicines and improve care.
The committee:
- reviews the safety and effectiveness of medicines
- recommends which medicines should be available for routine use
- considers requests for medicines that are not routinely available
- reviews and approves guidance for healthcare professionals
- uses feedback, audits and improvement work to make medicines safer and improve care.
If a medicine is not routinely available, the committee considers the evidence and the person’s individual clinical needs before a decision is made.
The committee’s work in 2025-26:
During the year, the committee:
- reviewed 186 requests for medicines that were not routinely available, approving 143
- approved updates to 17 medicines-related policies, procedures and guidelines
- supported new treatment options, including bupropion for treatment-resistant depression and guanfacine for adults with ADHD
- supported the introduction of take-home naloxone, which can reverse the effects of an opioid overdose in an emergency
- improved guidance and information to support people to make informed decisions about their medicines
- used learning from audits and improvement projects to make medicines safer and help reduce inequalities.